The evaluation of our whole Discovery cohort of 21 patients with metastatic melanoma, which included 16 cutaneous, 3 uveal and 2 mucosal melanomas, yielded a response-related transcriptome signature of 22 genes, with ALDH1A2 as the most DE gene. This evidence concerns the gene ALDH1A2 and melanoma.